Pharmaceutical Product Development, (PPD) was named the Best Contract Research Organization (CRO) at the 9th Vaccine Industry Excellence Awards at the World Vaccine Congress 2016.
Veteran entrepreneur, philanthropist and investor Fred Eshelman will receive the Life Science Leadership Award at the 25th annual CED Life Science Conference in March.
Updated January 14
PPD has wrapped up the spin-off X-Chem to its private equity owners, the Wilmington company says. The X-Chem deal was behind the "X-Co Holdings LP" mystery that unfolded after an SEC filing.
Updated January 14
The contract research organization business, which has a big hub in the Triangle with numerous major players based in the region, is headed toward seven years of plenty, according to a new report.
Updated January 14
Just in time for the return of the "X Files" on Fox, a mysterious "X-Co Holdings" company has emerged from the shadows in Wilmington, N.C. X-Co has numerous links to PPD and its private equity owners. PPD spun off a company, X-Chem.
Updated December 15, 2015
Is life science services company PPD for sale? A Reuters news report says it is, but so far the company isn't saying anything. Neither are the two private equity firms that own the Wilmington-based company.
December 3, 2015
INC Research, a fast-growing life science contract research organization, is the winner of the prestigious Scrip Award as the top CRO for 2015. Quintiles and PPD were also finalists.
Updated April 10, 2015
In today's Bulldog wrapup of technology and life science news: Startup Validic reports fast growth; LinkedIn's big acquisition; PPD forms a joint venture in Japan; Liquidia demos at vaccine congress; and Zynga's founder returns as CEO.
September 26, 2014
Wilmington-based PPD, which has a large presence in the Triangle, on Thursday bought the remaining minority interest in a Massachusetts firm which it originally acquired in 2010.
April 29, 2014
Looking back at Fred Eshelman's career: A 2009 blog post recapped a tumultuous year for Eshelman and PPD in which the company's stock was hammered and he stepped down as CEO to become executive chairman. But the year was capped with a salute. From there, Eshelman has continued to make headlines.
August 28, 2013
M&A dealmaking in the contract research organization sector strikes again as PPD buys a company. Read how the Acurian acquisition helps Wilmington-based PPD.
April 24, 2013
February 5, 2013
November 30, 2012
PPD's 3D technology for global training in clinical trials receives the Best Technological Development in Clinical Trials honor from Scrip, an international life science media and technology firm.
November 21, 2012
Oxygen Biotherapeutics picks PPD as the contract research organization to run a Phase 2 clinical trial on a proposed treatment for traumatic brain injury.
October 25, 2012
Clinical research organization Clinipace's fundraising haul today of $9 million puts it in a position to do more of what the Morrisville company has been doing in over the last two years - finding and acquiring companies.
Clinipace's website touts its growing reach, expertise
September 17, 2012
Inside the Bulldog Blog: SAS wins XL Group as Visual Analytics customer; PPD to work with Europeans on allergies; ATTUS expands compliance services; DARA licenses topical gel; Chemring wins big defense contract.
Updated September 13, 2012
Lowe's, PPD, SAS, Bank of America and Martin Marietta also crack the top 200 in the annual ranking of information technology trend-setters as selected by InformationWeek magazine.
June 18, 2012
May 23, 2012
David Simmons will take over as the leader of the Wilmington-based life science services company on June 4. PPD has been without a CEO since December.